Anebulo Pharmaceuticals Quarterly Balance Sheets Chart
Quarterly
|
Annual
Anebulo Pharmaceuticals Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|
| assets | |||
| current assets: | |||
| cash and cash equivalents | 5,147,139 | 6,644,517 | 8,520,578 |
| prepaid expenses | 223,676 | 171,740 | 527,306 |
| total current assets | 5,370,815 | 6,816,257 | |
| other assets: | |||
| loan commitment fees | 624,820 | 684,516 | |
| total assets | 5,995,635 | 7,500,773 | 9,047,884 |
| liabilities and stockholders’ equity | |||
| current liabilities: | |||
| accounts payable | 384,920 | 318,679 | 565,949 |
| accrued expenses | 625,401 | 694,877 | 150,611 |
| total liabilities | 1,010,321 | 1,013,556 | 716,560 |
| commitments and contingencies | |||
| stockholders’ equity: | |||
| preferred stock, 0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at march 31, 2024 and june 30, 2023 | |||
| common stock | 25,934 | 25,934 | 25,634 |
| additional paid-in capital | 69,013,155 | 68,861,516 | 67,988,554 |
| accumulated deficit | -64,053,775 | -62,400,233 | -59,682,864 |
| total stockholders’ equity | 4,985,314 | 6,487,217 | 8,331,324 |
| total liabilities and stockholders’ equity | 5,995,635 | 7,500,773 | 9,047,884 |
| preferred stock, 0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at december 31, 2023 and june 30, 2023 | |||
| preferred stock, 0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at september 30, 2023 and june 30, 2022 |
We provide you with 20 years of balance sheets for Anebulo Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Anebulo Pharmaceuticals. Explore the full financial landscape of Anebulo Pharmaceuticals stock with our expertly curated balance sheets.
The information provided in this report about Anebulo Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.